The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study
Sign Up to like & getrecommendations! Published in 2017 at "Pain Medicine"
DOI: 10.1093/pm/pnw139
Abstract: Objective. Current treatment strategies for painful critical ischemia in patients with end-stage renal disease (ESRD) are suboptimal. A drug that is non-renally excreted has minimal systemic absorption and does not require dose adjustment in renal… read more here.
Keywords: study; pain critical; critical ischemia; ischemia patients ... See more keywords